Quattromed
From Wikipedia, the free encyclopedia
| Quattromed Ltd | |
|---|---|
| Image:QM Logo | |
| Type | Privately held company |
| Founded | 1999 |
| Location | Tartu, Estonia |
| Key people | Erki Mölder, CEO |
| Industry | Biotechnology, Biopharmaceutical industry |
| Products | Products and services in functional genomics and proteomics |
| Certification | ISO 9001:2000 |
| Website | http://www.quattromed.com/ |
Quattromed Ltd is one of the leading biotechnology companies in Estonia[1] providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry.
Contents |
[edit] Profile
Quattromed was established in 1999 as a spin-off from Tartu University[2]. It is based in Tartu, Estonia. Employing 80 full-time employees, it has grown into the largest biotechnology company in Estonia. Quattromed started with offering molecular diagnostic services, the activities today cover molecular and clinical diagnostics (Quattromed HTI Laboratories), products of functional genomics and proteomics (Quattromed), and protein production (Quattromed Cell Factory).
[edit] Products and Services
Quattromed’s activities are divided into three branches: medical diagnostics division, technology development division and life science products division. Its main focus of activities is in protein expression and production. In-house proprietary technologies are used combined with extensive process know-how and partnership with academic and industrial groups. Quattromed has three patent applications in its IP portfolio, about ten technology licenses and one trade mark.
Quattromed’s main products are:
-
- FITkit (latex allergen test) and FITkit testing service
- E2Tag epitope tagging technology[3][4]
- MAbs to HIV/SIV proteins, epitope tags
- anti-IgG antibodies
- Quattromed Cell Factory, a new protein production technology (QMCF)
[edit] References
- ^ Frank L. (2001). "Biotechnology in the Baltic". Nature Biotechnology 19 (6): 513–5. PMID 11385442.
- ^ Estonian Biotechnology Association. Retrieved 18. June 2007.
- ^ Kurg R, Parik J, Juronen E, Sedman T, Abroi A, Liiv I, Langel U, Ustav M. (1999). "Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication". Journal of Virology 73 (6): 4670–7. doi:. PMID 11385442.
- ^ Kaldalu N, Lepik D, Kristjuhan A, Ustav M. (2000). "Monitoring and purification of proteins using bovine papillomavirus E2 epitope tags.". Biotechniques 28 (3): 456–60. PMID 10723557.
[edit] External links
- Quattromed Ltd. website
- Quattromed FITkit and latex allergen testing
- Quattromed life science product catalogue
